
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $47.1M | -- | -- | -$0.68 | -- |
08/06/2025 | Q2 | $43.6M | -- | -- | -$0.67 | -- |
05/07/2025 | Q1 | $40.2M | $32.7M | -$0.81 | -$0.68 | -$0.13 |
02/26/2025 | Q4 | $38.5M | $41.8M | -$0.72 | -$0.73 | $0.01 |
11/05/2024 | Q3 | $32.5M | $33.3M | -$0.73 | -$0.87 | $0.14 |
08/06/2024 | Q2 | $28.8M | $29.1M | -$0.55 | -$0.72 | $0.17 |
05/07/2024 | Q1 | $26.9M | $26M | -$2.35 | -$2.39 | $0.04 |
02/22/2024 | Q4 | $25.4M | $24.2M | -$0.70 | -$0.71 | $0.01 |
11/07/2023 | Q3 | -- | -- | -$0.76 | -$0.76 | -$0.00 |
08/01/2023 | Q2 | -- | -- | -$0.82 | -$0.78 | -$0.04 |
05/02/2023 | Q1 | -- | -- | -$0.92 | -$0.77 | -$0.15 |
03/01/2023 | Q4 | -- | -- | -$0.75 | -$0.78 | $0.03 |
11/08/2022 | Q3 | -- | -- | -$0.79 | -$0.98 | $0.19 |
08/02/2022 | Q2 | -- | -- | -$0.89 | -$1.03 | $0.14 |
05/03/2022 | Q1 | -- | -- | -$1.05 | -$1.04 | -$0.01 |
03/01/2022 | Q4 | -- | -- | -$0.85 | -$0.93 | $0.08 |
11/02/2021 | Q3 | -- | -- | -$0.70 | -$0.83 | $0.13 |
08/03/2021 | Q2 | -- | -- | -$0.70 | -$0.74 | $0.04 |
05/03/2021 | Q1 | -- | -- | $0.90 | -$0.70 | $1.60 |
03/01/2021 | Q4 | -- | -- | -$0.79 | -$0.79 | -- |
11/02/2020 | Q3 | -- | -- | -$0.77 | -$0.80 | $0.03 |
08/03/2020 | Q2 | -- | -- | -$0.71 | -$0.82 | $0.11 |
05/04/2020 | Q1 | -- | -- | -$0.78 | -$0.82 | $0.04 |
03/02/2020 | Q4 | -- | -- | -$0.78 | -$0.92 | $0.14 |
11/01/2019 | Q3 | -- | -- | -$1.04 | -$1.10 | $0.06 |
07/29/2019 | Q2 | -- | -- | -$1.24 | -$0.85 | -$0.39 |
05/03/2019 | Q1 | -- | -- | -$0.84 | -$0.73 | -$0.11 |
03/08/2019 | Q4 | -- | -- | -$0.74 | -$0.66 | -$0.08 |
11/09/2018 | Q3 | -- | -- | -$0.52 | -$0.61 | $0.09 |
08/08/2018 | Q2 | -- | -- | -$0.52 | -$0.47 | -$0.05 |
05/14/2018 | Q1 | -- | -- | -$0.60 | -- | -- |
03/12/2018 | Q4 | -- | -- | -$0.41 | -$0.55 | $0.14 |
11/14/2017 | Q3 | -- | -- | -$0.66 | -$0.56 | -$0.11 |
Rhythm Pharmaceuticals reported $32.7M worth of top line sales in its most recent quarter.
Rhythm Pharmaceuticals announced earnings per share of -$0.81 which represents a miss of analyst forecast a -$0.68 per share.
Rhythm Pharmaceuticals reported $29.1M that represents $0.46 per share over the last quarter.
Rhythm Pharmaceuticals's earnings are forecast to decrease from -$4.34 per share to -$4.07 per share next year representing a decrease of -34.54%.
Rhythm Pharmaceuticals's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.